Search
Terlakiren
go.drugbank.com/drugs/DB20615ExperimentalTerlakiren is a small molecule drug. The usage of the INN stem '-kiren' in the name indicates that Terlakiren is a renin inhibitor. Terlakiren has a monoisotopic molecular weight of 620.32 Da.
Clodacaine
go.drugbank.com/drugs/DB20755ExperimentalClodacaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Clodacaine is a local anaesthetic. Clodacaine has a monoisotopic molecular weight of 311.18 Da.
Fosazepam
go.drugbank.com/drugs/DB19580ExperimentalFosazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Fosazepam is a diazepam derivative. Fosazepam has a monoisotopic molecular weight of 360.08 Da.
Fomocaine
go.drugbank.com/drugs/DB19969ExperimentalFomocaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Fomocaine is a local anaesthetic. Fomocaine has a monoisotopic molecular weight of 311.19 Da.
Avizafone
go.drugbank.com/drugs/DB20094ExperimentalAvizafone is a small molecule drug. The usage of the INN stem '-zafone' in the name indicates that Avizafone is a alozafone derivative. Avizafone has a monoisotopic molecular weight of 430.18 Da.
Metoxepin
go.drugbank.com/drugs/DB21433ExperimentalMetoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.
Rizedisben
go.drugbank.com/drugs/DB21610InvestigationalRizedisben is a small molecule drug. Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). … Rizedisben has a monoisotopic molecular weight of 519.22 Da.
Davelizomib
go.drugbank.com/drugs/DB21660ExperimentalDavelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.
AM103
go.drugbank.com/drugs/DB05225ExperimentalAM103 is a novel inhibitor of 5-lipoxygenase-activiting protein (FLAP) that has demonstrated potential to treat asthma and cardiovascular disease by preventing the synthesis of LT, which triggers inflammation
Eperisone
go.drugbank.com/drugs/DB08992InvestigationalEperisone is an antispasmodic drug which relaxes both skeletal muscles and vascular smooth muscles, and demonstrates a variety of effects such as reduction of myotonia, improvement of circulation, and … It is not approved for use in the United States, but is available in other countries like India, South Korea, and Bangladesh.